HomeMDG1 • ETR
add
MediGene AG
Nakaraang pagsara
€1.20
Sakop ng araw
€1.13 - €1.18
Sakop ng taon
€1.06 - €2.74
Market cap
35.07M EUR
Average na Volume
30.09K
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(EUR) | Dis 2023info | Y/Y na pagbabago |
---|---|---|
Kita | 1.48M | -50.19% |
Gastos sa pagpapatakbo | 5.51M | 42.24% |
Net na kita | -4.60M | 58.62% |
Net profit margin | -310.00 | 16.92% |
Kita sa bawat share | — | — |
EBITDA | -4.24M | -148.75% |
Aktuwal na % ng binabayarang buwis | -3.53% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(EUR) | Dis 2023info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 16.67M | -49.81% |
Kabuuang asset | 31.72M | -38.63% |
Kabuuang sagutin | 10.65M | -27.31% |
Kabuuang equity | 21.07M | — |
Natitirang share | 24.56M | — |
Presyo para makapag-book | 1.39 | — |
Return on assets | -34.59% | — |
Return on capital | -45.68% | — |
Cash Flow
Net change in cash
(EUR) | Dis 2023info | Y/Y na pagbabago |
---|---|---|
Net na kita | -4.60M | 58.62% |
Cash mula sa mga operasyon | -3.54M | -33.03% |
Cash mula sa pag-invest | -85.50K | 77.96% |
Cash mula sa financing | -306.50K | -2,454.17% |
Net change in cash | -3.94M | -27.88% |
Malayang cash flow | -2.54M | -127.72% |
Tungkol
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Itinatag
1994
Headquarters
Website
Mga Empleyado
76